Brief: Pacific Biosciences of California Q2 Adjusted EPS USD -0.26 Vs. IBES Estimate USD -0.32
02/08/2023 21:06
Aug 02 (Reuters) - Pacific Biosciences of California Q2 adjusted net income USD -65.6 million. * Q2 adjusted gross profit USD 15.7 million * Q2 adjusted gross margin 33% * Q2 revenue USD 47.6 million vs. IBES estimate USD 40.3 million * Q2 EPS USD -0.28
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview